首页> 外文期刊>Breast Cancer Research and Treatment >RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo
【24h】

RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo

机译:RACK1在体外和体内促进乳腺癌的增殖和侵袭/转移

获取原文
获取原文并翻译 | 示例
       

摘要

A yeast two-hybrid system was utilized to identify novel PI3K p110α-interacting proteins, of which receptor of activated protein kinase C1 (RACK1) was chosen for successive detailed analyses. Our aim was to investigate the function(s) of RACK1 and its involvement in mechanisms of breast carcinoma proliferation and invasion/metastasis. Experiments in breast carcinoma cell lines stably transfected with RACK1, as well as nude mouse models, showed that RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo. Conversely, knockdown of RACK1 by siRNA in vitro inhibited proliferation, migration, and invasion. In cell lines stably transfected with RACK1, p-AKT, cyclin D1, cyclin D3, and CD147 expression, as well as MMP2 activity, were elevated. RACK1-induced migration could be inhibited by the addition of Rho-kinase inhibitor. In 160 breast carcinoma cases, survival analyses established that RACK1 is an independent prognostic factor for poor outcome (P < 0.001). In conclusion, RACK1 is an independent prognosis-related factor and promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo.
机译:利用酵母双杂交系统鉴定新型的PI3Kp110α相互作用蛋白,并选择了活化蛋白激酶C1(RACK1)的受体进行连续的详细分析。我们的目的是研究RACK1的功能及其在乳腺癌增殖和侵袭/转移机制中的作用。在用RACK1稳定转染的乳腺癌细胞系以及裸鼠模型中进行的实验表明,RACK1在体外和体内均可促进乳腺癌的增殖和侵袭/转移。相反,在体外通过siRNA敲低RACK1可抑制增殖,迁移和侵袭。在用RACK1稳定转染的细胞系中,p-AKT,细胞周期蛋白D1,细胞周期蛋白D3和CD147的表达以及MMP2活性均升高。通过添加Rho激酶抑制剂可以抑制RACK1诱导的迁移。在160例乳腺癌病例中,生存分析确定RACK1是不良预后的独立预后因素(P <0.001)。总之,RACK1是一个独立的预后相关因素,在体外和体内均可促进乳腺癌的增殖和侵袭/转移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号